Bill Title: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2024-12-09 - Read twice and referred to the Committee on Finance. [SB5459 Detail]

Text: Not Available

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress SB5459 at this time.

Social Comments on US SB5459